Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

 
ORIGINAL ARTICLE
Ahead of print publication  

Nuclear factor-kappa B as potential therapeutic target in human colon cancer


1 Department of Cytophysiology, Chair of Histology and Embryology, Medical University of Silesia, Medyków 18, Katowice, Poland
2 Department of Proteomics, Medical University of Silesia, 41-200 Sosnowiec, Poland

Correspondence Address:
Danuta Plewka,
Department of Cytophysiology, Chair of Histology and Embryology, Medical University of Silesia, Medyków 18, 40-752 Katowice
Poland
Login to access the Email id

Source of Support: None, Conflict of Interest: None

 > Abstract 


Background: It has been proved that nuclear factor-kappa B (NF-κB) is activated in all cells, promotes proliferation of cells, regulates the immunological and inflammatory response, and contribute to the pathogenesis of many conditions, including cancer. Many studies pointed to constitutive activation of NF-κB in cells of certain malignant tumors.
Objective: The aim of the study was to analyze the role of nuclear growth factor κB as colon cancer marker and prognostic factor.
Materials and Methods: The study included 59 primary colorectal tumor patients and 15 patients in control group. The tumor samples were taken during partial colectomy and colonoscopy in control group. Tissues samples were fixed and embedded in paraffin blocks and cut. Sections were used for schedule immunohistochemical staining with the application of specific antibody for NF-κB epitope. The marker expression was compared with well-known prognostic factors in colon tumors such as tumor type, stage, and grade to establish if it might be a potential prognostic factor.
Results: The results showed statistically significant difference between control group and cancer group.
Conclusions: The expression NF-κB did not depend on the stage and grade of colon tumors.

Keywords: Colon cancer, nuclear factor-kappa B, stages of neoplastic differentiation



How to cite this URL:
Plewka D, Plewka A, Miskiewicz A, Morek M, Bogunia E. Nuclear factor-kappa B as potential therapeutic target in human colon cancer. J Can Res Ther [Epub ahead of print] [cited 2017 Jul 23]. Available from: http://www.cancerjournal.net/preprintarticle.asp?id=180607

.




 

 
Top
 
 
  Search
 
     Search Pubmed for
 
    -  Plewka D
    -  Plewka A
    -  Miskiewicz A
    -  Morek M
    -  Bogunia E
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  >Abstract
  In this article

 Article Access Statistics
    Viewed483    
    PDF Downloaded23    

Recommend this journal